CRISPR/Cas9 technology generated a tyrosine to cysteine substitution at amino acid 392 (p.Y392C). This is a pathogenic variant identified in children with Zaki syndrome consisting of multiorgan defects, microcephaly and facial dysmorphism. (J:341542)